Trial Profile
Phase IIa proof-of-concept study of Depomed's omeprazole in patients with GERD
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2018
Price :
$35
*
At a glance
- Drugs Omeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Pharmacodynamics; Pharmacokinetics; Proof of concept
- Sponsors Depomed
- 12 Nov 2007 New trial record.